In:
Clinical Science, Portland Press Ltd., Vol. 96, No. 3 ( 1999-03-01), p. 235-239
Kurzfassung:
Recent evidence demonstrates that hyperhomocyst(e)inaemia is a novel risk factor for cardiovascular diseases. In patients with chronic hyperhomocyst(e)inaemia, endothelial function is impaired. However, whether hyperhomocyst(e)inaemia per se is a cause or an epiphenomenon of endothelial dysfunction remains unknown. In this study, we examined the effects of methionine-induced acute hyperhomocyst(e)inaemia on human endothelial function. In healthy volunteers we administered methionine (0.1 ;g/kg body weight, per os), a substrate of homocyst(e)ine, with or without folic acid (20 ;mg, per os) and examined flow-mediated vasodilatation of the brachial artery by high-resolution ultrasonography as a non-invasive measure of endothelial function. We also measured plasma levels of homocyst(e)ine before and 3, 8 and 24 ;h after methionine loading. Methionine administration increased plasma levels of homocyst(e)ine by four times the basal level at 8 ;h (P 〈 0.0001, ANOVA). The plasma levels returned to baseline at 24 ;h. Flow-mediated vasodilatation was significantly decreased to half of the baseline value at 8 ;h and returned to baseline at 24 ;h (P 〈 0.0001, ANOVA), whereas endothelium-independent vasodilatation by glyceryl trinitrate was not affected by the methionine loading. Co-administration of folic acid did not attenuate methionine-induced hyperhomocyst(e)inaemia but completely prevented endothelial dysfunction. Our results suggest that in humans a methionine-rich diet may acutely impair endothelial function, which can be prevented by folic acid supplementation.
Materialart:
Online-Ressource
ISSN:
0143-5221
,
1470-8736
Sprache:
Englisch
Verlag:
Portland Press Ltd.
Publikationsdatum:
1999
